Abstract
Every year millions of people, particularly children, die of diseases for which a vaccine exists (Walsh, 1988; Warren, 1989). Countless others are left blinded, mentally retarded, or severely crippled. The problem is most significant in developing countries where access to health care is poor. In these countries, it is estimated that more than half of the children who receive primary vaccinations do not complete their required booster immunization schedule (Aguado, 1993; Bloom, 1989). These children are left unprotected, accounting for the enormous number of reported deaths.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ada, G., 1991, Strategies for exploiting the immune system in the design of vaccines, Mol. Immunol. 28(3):225–230.
Aguado, M. T., 1993, Future approaches to vaccine development: Single-dose vaccines using controlledrelease delivery systems, Vaccine 11(5):596–597.
Aguado, M. T., and Lambert, P.-H., 1992, Controlled-release vaccines — Biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles, Immunobiology 184:113–125.
Allcock, H. R., and Kwon, S., 1989, An ionically cross-linkable polyphosphazene: Poly[bis(carboxylatophenoxy)phosphazene] and its hydrogels and membranes, Macromolecules 22:75–79.
Alonso, M. J., Cohen, S., Park, T. G., Gupta, R. K., Siber, G. R., and Langer, R., 1993, Determinants of release rate of tetanus vaccine from polyester microspheres, Pharm. Res. 10(7):945–953.
Alonso, M. J., Gupta, R. K., Min, C., Siber, G. R., and Langer, R., 1994, Biodegradable microspheres as controlled release tetanus toxoid delivery systems, Vaccine 12(4):299–306.
Andrianov, A. K., Payne, L. G., Visscher, K. B., Allcock, H. R., and Langer, R., Hydrolytic degradation of ionically cross-linked polyphosphazene microspheres, J. Appl. Polym. Sci. 53:1573-1578.
Arakawa, T., Prestrelski, S. J., Kenney, W. C., and Carpenter, J. F., 1993, Factors affecting short-term and long-term stabilities of proteins, Adv. Drug Deliv. Rev. 10:1–28.
Bloom, B. R., 1989, Vaccines for the third world, Nature 342:115–120.
Bomford, R., Stapleton, M., and Winsor, S., 1991, Immunomodulation by adjuvants, in: Vaccines (G. Gregoriadis, A. C. Allison, and G. Poste, eds.), Plenum Press, New York, pp. 25–32.
Carr, I., 1973, The Macrophage: A Review of Ultrastructure and function, Academic Press, New York.
Cohen, S., Baño, M. C., Visscher, K. B., Chow, M., Allcock, H. R., and Langer, R., 1990, Ionically cross-linkable polyphosphazene: A novel polymer for microencapsulation, J. Am. Chem. Soc. 112:7832–7833.
Cohen, S., Bernstein, H., Hewes, C., Chow, M., and Langer, R., 1991a, The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes, Proc. Natl. Acad. Sci. USA 88:10440–10444.
Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. H., and Langer, R., 1991b, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm. Res. 8(6):713–720.
Cohen, S., Cochrane, A., Nardin, E., and Langer, R., 1992, Poly(lactic/glycolic acid) microspheres — Immunization vehicles for synthetic peptide vaccines, Polym. Mater. Sci. Eng. 66:91–92.
Cohen, S., Alonso, M. J., and Langer, R., 1994, Novel approaches to controlled release antigen delivery, in: Int. J. Tech. Assess. Health Care (A. Robbins and P. Freeman, eds.), Cambridge University Press, London, pp. 121–130.
Donbrow, M., 1992, Developments in phase separation methods, aggregation control, and mechanisms of microencapsulation, in: Microcapsules and Nanoparticles in Medicine and Pharmacy (M. Donbrow, ed.), CRC Press, Boca Raton, pp. 17–45.
Edelman, R., 1980, Vaccine adjuvants, Rev. Infect. Dis. 2(3):370–383.
Edelman, R., Russell, R. G., Losonsky, G., Tall, B. D., Tacket, C. O., Levine, M. M., and Lewis, D. H., 1993, Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly(lactide-co-glycolide), Vaccine 11(2): 155–158.
Eldridge, J. H., Meulbroek, J. A., Staas, J. K., Tice, T. R., and Gilley, R.M., 1989, Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response, Adv. Exp. Med. Biol. 251:192–202.
Eldridge, J. H., Hammond, C. J., and Meulbroek, J. A., 1990, Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer’s patches, J. Control. Rel. 11:205–214.
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., McGhee, J. R., Tice, T. R., and Gilley, R. M., 1991a, Biodegradable microspheres as a vaccine delivery system, Mol. Immunol. 28(3):287–294.
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R., and Gilley, R. M., 1991b, Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies, Infect. Immun. 59:2978–2986.
Eppstein, D. A., Marsh, Y. V., van der Pas, M. A., Feigner, P. L., and Schreiber, A. B., 1985, Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrane receptor, Proc. Natl. Acad. Sci. USA 82:3688–3692.
Evans, R., and Alexander, P., 1972, Mechanism of immunologically specific killing of tumor cells by macrophages, Nature 236:168–170.
Fidler, I. J., Darnell, J. H., and Budmen, M. B., 1976, Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A, Cancer Res. 36:3608–3615.
Fong, J. W., 1979, Processes for preparation of microspheres, U.S. Patent 4,166,800.
Freund, J., 1956, The mode of action of immunological adjuvants, Adv. Tuberc. Res. 7:130–148.
Gander, B., Thomasin, C., Merkle, H. P., Men, Y., and Corradin, G., 1993, Pulsed tetanus toxoid release from PLGA-microspheres and its relevance for immunogenicity in mice, in: Proc. Int. Symp. Control. Rel. Bioact. Mater., Controlled Release Society, Washington, DC, pp. 65–66.
Gibbons, A., 1992, A booster shot for children’s vaccines, Science 255:1351.
Gilding, D. K., and Reed, A. M., 1979, Biodegradable polymers for use in surgery: Polyglycolic/poly(lactic acid) homo-and copolymers: 1, Polymer 20:1459–1464.
Gilley, R. M., Staas, J. K., Tice, T. R., Morgan, J. D., and Eldridge, J. H., 1992, Microencapsulation and its application to vaccine development, in: Proc. Int. Symp. Control. Rel. Bioact. Mater., Controlled Release Society, Orlando, pp. 110–111.
Glenny, A. T., Buttle, G. A. H., and Stevens, M. F., 1931, Rate of disappearance of diphtheria toxoid injected into rabbits and guinea-pigs: Toxoid precipitated with alum, J. Pathol. Bacteriol. 34:267–275.
Gupta, R. K., Siber, G. R., Alonso, M. J., and Langer, R., 1993, Development of a single dose tetanus toxoid based on controlled release from biodegradable and biocompatible polyester microspheres, in: Vaccines 93 (F. Brown, R. Chenock, H. Ginsberg, and R. Lerner, eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 391–396.
Hanes, J., and Langer, R., 1995, Polymeric controlled release vaccine delivery systems, in: Reproductive Immunology (R. Bronson, N. Alexander, D. Anderson, D. W. Branch, and W. H. Kutteh, eds.), Blackwell, Oxford (in press).
Hibbs, J. B. Jr., Taintor, R. R., Chapman, H. A. Jr., and Weinberg, J. B., 1977, Macrophage tumor killing: Influence of the local environment, Science 197:279–282.
Kibat, P. G., Igari, Y., Wheatley, M. A., Eisen, H. N., and Langer, R., 1990, Enzymatically activated microencapsulated liposomes can provide pulsatile drug release, FASEB J. 4:2533–2539.
Kohn, J., and Langer, R., 1986, Poly(iminocarbonates) as potential biomaterials, Biomaterials 7:176–182.
Kohn, J., and Langer, R., 1987, Polymerization reactions involving the side chains of alpha-L-amino acids, J. Am. Chem. Soc. 109:817–820.
Kohn, J., Niemi, S. M., Albert, E. C., Murphy, J. C., Langer, R., and Fox, J. G., 1986, Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity, J. Immunol. Methods 95:31–38.
Kost, J., and Langer, R., 1992, Responsive polymer systems for controlled delivery of therapeutics, Trends Biotechnol. 10(4):127–131.
Kraehenbuhl, J.-P., and Neutra, M. R., 1992, Transepithelial transport and mucosal defence II: Secretion of IgA, Trends Cell Biol. 2:170–174.
Langer, R., 1981, Polymers for the sustained release of macromolecules: Their use in a single-step method of immunization, Methods Enzymol. 73:57–75.
Langer, R., 1990, New methods of drug delivery, Science 249:1527–1533.
Lewis, D. H., 1990, Controlled release of bioactive agents from lactide/glycolide polymers, in: Biodegradable Polymers as Drug Delivery Systems (M. Chasin and R. Langer, eds.), Dekker, New York, pp. 1–41.
Liu, R., Langer, R., and Klibanov, A. M., 1991, Moisture-induced aggregation of lyophilized proteins in the solid state, Biotechnol. Bioeng. 37:177–184.
McQueen, C. E., Boedeker, E. C., Reid, R., Jarboe, D., Wolf, M., Le, M., and Brown, W. R., 1993, Pili in microspheres protect rabbits from diarrhoea induced by E. coli strain RDEC-1, Vaccine 11(2): 201–206.
Mitchison, N.A., 1990, Gonadotrophin vaccines, Curr. Opin. Immunol. 2:725–727.
Moldoveanu, Z., Staas, J. K., Gilley, R. M., Ray, R., Compans, R. W., Eldridge, J. H., Tice, T. R., and Mestecky, J., 1989, Immune responses to influenza virus in orally and systemically immunized mice, Curr. Top. Microbiol. Immunol. 146:91–99.
Moldoveanu, Z., Novak, M., Huang, W. Q., Gilley, R. M., Staas, J. K., Schafer, D., Compans, R. W., and Mestecky, J., 1993, Oral immunization with influenza virus in biodegradable microspheres, J. Infect. Dis. 167(1):84–90.
Neutra, M. R., and Kraehenbuhl, J.-P., 1992, Transepithelial transport and mucosal defence I: The role of M cells, Trends Cell Biol. 2:134–138.
O’Hagan, D. T., 1990, Intestinal translocation of particulates — Implications for drug and antigen delivery, Adv. Drug Deliv. Rev. 5:265–285.
O’Hagan, D. T., Jeffery, H., and Davis, S. S., 1993a, Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles, Vaccine 11(9):965–969.
O’Hagan, D. T., McGee, J. P., Holmgren, J., Mowat, A. M., Donachie, A. M., Mills, K. H. G., Gaisford, W., Rahman, D., and Challacombe, S. J., 1993b, Biodegradable microparticles for oral immunization, Vaccine 11:149–154.
Okada, H., Inoue, Y., Heya, T., Ueno, H., Ogawa, Y., and Toguchi, H., 1991, Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate, Pharm. Res. 8:787–791.
Payne, L. G., Jenkins, S. A., Andrianov, A., Langer, R., and Roberts, B. E., 1995, Xenobiotic polymers as vaccine vehicles, in: Advances in Experimental Medicine and Biology (J. R. McGee and J. Mestecky, eds.), Plenum Press, New York (in press).
Preis, I., and Langer, R., 1979, A single-step immunization by sustained antigen release, J. Immunol. Methods. 28:193–197.
Reid, R. H., Boedeker, E. C., McQueen, C. E., Davis, D., Tseng, L.-Y, Kodak, J., Sau, K., Wilhelmsen, C. L., Nellore, R., Dalai, P., and Bhagat, H. R., 1993, Preclinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli, Vaccine 11(2): 159–167.
Santiago, N., Milstein, S. J., Rivera, T., Garcia, E., Chang, T. C., Baughman, R. A., and Bucher, D., 1992, Oral immunization of rats with influenza virus M protein (Ml) microspheres, in: Proc. Int. Symp. Control Rel Bioact. Mater., Controlled Release Society, Orlando, pp. 116–117.
Schneider, A. K., 1972, Polylactide sutures, U.S. Patent 3,636,956.
Schreier, H., Levy, M., and Milhalko, P., 1987, Sustained release of liposome-encapsulated gentamicin and fate of phospholipid following intramuscular injection in mice, J. Control. Rel. 5:187–192.
Staas, J. K., Hunt, R. E., Marx, P. A., Compans, R. W., Smith, J. F., Eldridge, J. H., Gibson, J. W., Tice, T. R., and Gilley, R. M., 1993, Mucosal immunization using microsphere delivery systems, in: Proc. Int. Symp. Control Rel. Bioact. Mater., Controlled Release Society, Washington, DC, pp. 63–64.
Stevens, V. C., 1993, Vaccine deblivery systems: Potential methods for use in antifertility vaccines, Am. J. Reprod. Immunol. 29:176–188.
Stevens, V. C., Powell, J. E., Lee, A. E., Kaumaya, P. T. P., Lewis, D. H., Rickey, M., and Atkins, T. J., 1992, Development of a delivery system for a birth control vaccine using biodegradable microspheres, in: Proc. Int. Symp. Control Rel. Bioact. Mater., Controlled Release Society, Orlando, pp. 112–113.
Tabata, Y., and Ikada, Y., 1986, Phagocytosis of bioactive microspheres, J. Bioact. Compat. Polym. 1:32–46.
Tabata, Y., and Ikada, Y., 1987, Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres, J. Pharm. Pharmacol. 39:698–704.
Tabata, Y., and Ikada, Y., 1988a, Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage, Biomaterials 9(4):356–362.
Tabata, Y., and Ikada, Y., 1988b, Macrophage phagocytosis of biodegradable microspheres composed of L-lactic/glycolic acid homo-and copolymers, J. Biomed. Mater. Res. 22:837–858.
Tabata, Y., and Ikada, Y., 1989a, Protein precoating of polylactide microspheres containing a lipophibc immunopotentiator for enhancement of macrophage phagocytosis and activation, Pharm. Res. 6(4):296–301.
Tabata, Y., and Ikada, Y., 1989b, Synthesis of gelatin microspheres containing interferon, Pharm. Res. 6(5):422–427.
Tabata, Y., and Ikada, Y., 1990, Drug debvery systems for antitumor activation of macrophages, Crit. Rev. Then Drug Carrier Syst. 7(2): 121–148.
Tabata, Y., Nakaoka, R., and Ikada, Y., 1993, Potentiality of gelatin microspheres as an immunological adjuvant, in: Proc. Int. Symp. Control. Rel. Bioact. Mater., Controlled Release Society, Washington, DC, pp. 392–393.
Talwar, G. P., and Raghupathy, R., 1989, Anti-fertibty vaccines, Vaccine 7:97–101.
Tice, T. R., and Tabibi, S. E., 1992, Parenteral drug delivery: Injectables, in: Treatise on Controlled Drug Delivery (A. Kydonieus, ed.), Dekker, New York, pp. 315–339.
Volkin, D. B., and Klibanov, A. M., 1989, Minimizing protein inactivation, in: Protein Function: A Practical Approach (T. E. Creighton, ed.), IRL Press, Oxford, pp. 1–24.
Walsh, J. A., 1988, Establishing health priorities in the developing world, United Nations Development Programme, Report.
Warren, K. S., 1989, The biotechnology and children’s revolutions, in: Immunization (R. K. Root, K. S. Warren, J. Griffiss, and M. A. Sande, eds.), Churchill Livingstone, Edinburgh, pp. 1–9.
Weiner, A. L., Carpenter-Green, S. S., Soehngen, E. C., Lenk, R. P., and Popescu, M. C., 1985, Liposomecollagen gel matrix: A novel sustained drug delivery system, J. Pharm. Sci. 74(9):922–925.
Wheeler, A. W., Moran, D. M., Robins, B. E., and Driscoll, A., 1982, L-Tyrosine as an immunological adjuvant, Int. Arch. Allergy Appl. Immun. 69:113–119.
Wheeler, A. W., Whittall, N., Spackman, V., and Moran, D. M., 1984, Adjuvant properties of hydrophobic derivatives prepared from L-tyrosine, Int. Arch. Allergy Appl. Immunol. 75:294–299.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hanes, J., Chiba, M., Langer, R. (1995). Polymer Microspheres for Vaccine Delivery. In: Powell, M.F., Newman, M.J. (eds) Vaccine Design. Pharmaceutical Biotechnology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1823-5_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1823-5_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5737-7
Online ISBN: 978-1-4615-1823-5
eBook Packages: Springer Book Archive